RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/29618934/ below:

Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography

. 2018 Mar 26:10:157-167. doi: 10.2147/CEOR.S150260. eCollection 2018. Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography

Affiliations

¹ Value Based Care, Outcomes Research, Truven Health Analytics, an IBM Company, Bethesda, MD USA.
² Value Based Care, Outcomes Research, Truven Health Analytics, an IBM Company, Newark, NJ, USA.
³ Seno Medical Instruments, Inc., San Antonio, TX, USA.

PMID: 29618934
PMCID: PMC5875586
DOI: 10.2147/CEOR.S150260

Item in Clipboard

Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography

Anna Vlahiotis et al. Clinicoecon Outcomes Res. 2018.

. 2018 Mar 26:10:157-167. doi: 10.2147/CEOR.S150260. eCollection 2018. Affiliations

¹ Value Based Care, Outcomes Research, Truven Health Analytics, an IBM Company, Bethesda, MD USA.
² Value Based Care, Outcomes Research, Truven Health Analytics, an IBM Company, Newark, NJ, USA.
³ Seno Medical Instruments, Inc., San Antonio, TX, USA.

PMID: 29618934
PMCID: PMC5875586
DOI: 10.2147/CEOR.S150260

Item in Clipboard

Abstract

Background: Little data exist on real-world patterns and associated costs of downstream breast diagnostic procedures following an abnormal screening mammography or clinical exam.

Objectives: To analyze the utilization patterns in real-world clinical settings for breast imaging and diagnostic procedures, including the frequency and volume of patients and procedures, procedure sequencing, and associated health care expenditures.

Materials and methods: Using medical claims from 2011 to 2015 MarketScan Commercial and Medicare Databases, adult females with breast imaging/diagnostic procedures (diagnostic mammography, ultrasound, molecular breast imaging, tomosynthesis, magnetic resonance imaging, or biopsy) other than screening mammography were selected. Continuous health plan coverage without breast diagnostic procedures was required for ≥13 months before the first found breast diagnostic procedure (index event), with a 13-month post-index follow-up period. Key outcomes included diagnostic procedure volumes, sequences, and payments. Results reported descriptively were projected to provide US national patient and procedure volumes.

Results: The final sample of 875,526 patients was nationally projected to 12,394,432 patients annually receiving 8,732,909 diagnostic mammograms (53.3% of patients), 6,987,399 breast ultrasounds (42.4% of patients), and 1,585,856 biopsies (10.3% of patients). Following initial diagnostic procedures, 49.4% had second procedures, 20.1% followed with third procedures, and 10.0% had a fourth procedure. Mean (SD) costs for diagnostic mammograms of US$349 ($493), ultrasounds US$132 ($134), and biopsies US$1,938 ($2,343) contributed US$3.05 billion, US$0.92 billion, and US$3.07 billion, respectively, to annual diagnostic breast expenditures estimated at US$7.91 billion.

Conclusion: The volume and expense of additional breast diagnostic testing, estimated at US$7.91 billion annually, underscores the need for technological improvements in the breast diagnostic landscape.

Keywords: breast cancer; diagnosis; expenditures; health care utilization; imaging; mammography.

PubMed Disclaimer

Conflict of interest statement

Disclosure Anna Vlahiotis, Brian Griffin, and Jay Margolis are employees of Truven Health Analytics, an IBM company, which was paid by Seno Medical Instruments in connection with the development of this paper. Thomas Stavros is an employee of Seno Medical Instruments. The authors report no other conflicts of interest in this work.

Figures
Figure 1

Two most common breast imaging…

Figure 1

Two most common breast imaging and diagnostic care paths, with projected annual US…

Figure 1

Two most common breast imaging and diagnostic care paths, with projected annual US patient and procedure volumes^a,b. Notes: ^aPatient and procedure volumes only reflect those of the two most common care paths and do not equal the total volume for all procedure types. ^bThese are annual patient and procedure volumes, projected to the US national population.